NanoString Competitors and Similar CompaniesClear all
NanoString's competitors and similar companies include Personalis, Viapath and 10X Genomics.
 NanoString NS Wind Down (formerly NanoString Technologies) is a provider of life science tools for translational research and molecular diagnostics. |  Viapath Viapath provides pathology and testing its partners, and NHS and private sector organizations. |  10X Genomics 10X Genomics is a company building products for research institutions and pharmaceutical companies across the life sciences, including oncology, immunology, and neuroscience. | ||
Founding Date | Founding Date 2003 | Founding Date 2011 | Founding Date 2009 | Founding Date 2012 |
Type | Type Subsidiary | Type Public | Type Private | Type Public |
Tags | ||||
Locations | Locations Seattle, US HQ Amsterdam, NL | Locations Fremont, US HQ West Wickham, GB | Locations Bedford, GB HQ London, GB London, GB London, GB London, GB Orpington, GB | Locations Pleasanton, US HQ Shanghai, CN Leiden, NL Singapore, SG San Francisco, US |
Employees | Employees 7038% decrease | Employees 22344% decrease | Employees 2701% decrease | Employees 1,17810% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 340.9 m | Valuation ($) N/A | Valuation ($) 1.9 b |
Financial | ||||
Revenue (est.) | Revenue (est.) $127.3m (FY, 2022) | Revenue (est.) $69.6m (FY, 2025) | Revenue (est.) £122m (FY, 2018) | Revenue (est.) $642.8m (FY, 2025) |
Cost of goods | Cost of goods $65.5m (FY, 2022) | Cost of goods $53.9m (FY, 2025) | Cost of goods £88.9m (FY, 2018) | Cost of goods $198.9m (FY, 2025) |
Gross profit | Gross profit $61.8m (FY, 2022) | Gross profit $15.8m (FY, 2025) | Gross profit £33.1m (FY, 2018) | Gross profit $443.9m (FY, 2025) |
Net income | Net income ($159.5m) (FY, 2022) | Net income ($81.3m) (FY, 2025) | Net income £2.5m (FY, 2018) | Net income ($43.5m) (FY, 2025) |
Operating ⚠ | ||||
Patents Issued | Patents Issued N/A | Patents Issued 16 (FY, 2021) | Patents Issued N/A | Patents Issued 200 (FY, 2019) |
Funding | ||||
Total funding raised | Total funding raised $ 152m | Total funding raised $ 75m | Total funding raised N/A | Total funding raised $ 195.5m |
For sources of this data, please see the company profile
View Company Profiles
Personalis
HQ
Fremont, US
Employees
223↓ 44% decrease
Personalis is a biotechnology company that specializes in cancer genomics.
View companyViapath
HQ
Bedford, GB
Employees
270↓ 1% decrease
Viapath provides pathology and testing its partners, and NHS and private sector organizations.
View company10X Genomics
HQ
Pleasanton, US
Employees
1,178↓ 10% decrease
10X Genomics is a company building products for research institutions and pharmaceutical companies across the life sciences, including oncology, immunology, and neuroscience.
View company